Lonza Cologne GmbH
- Lonza Cologne GmbH Nattermannallee 1 Cologne 50829 Germany
Lonza has developed Amaxa nucleofector kits for the transfection of primary mouse B cells from single reactions up to 96-well transfections.
Lonza has developed the Amaxa Basic Parasite Nucleofector Kit, providing transfection efficiencies up to 1,000 times higher compared to methods such as electroporation or particle bombardment.
Amaxa will host a free webinar on the Nucleofection of Stem Cells which is scheduled for 3 June 2008 (Europe, Japan) and 4 June (USA)
The HudsonAlpha Institute for Biotechnology will utilise Amaxa's Nucleofector technology as a core technology in certain research projects
Amaxa and Promega will provide cell biologists broader access to monitor cell signaling events in difficult-to- transfect cells, including stem cells, cancer cells and primary cells